InnoCare Pharma (09969) will issue a total of 204.48 million new RMB shares under the 2023 RMB Stock Incentive Plan.

date
16:28 15/07/2026
avatar
GMT Eight
Nuo Cheng Jianhua (09969) announced that on July 15, 2026, according to the 2023 Renminbi Stock Incentive Plan, a total of 512,500 new Renminbi shares were issued to 2 directors as the attribution results for the third attribution period. (Adopted on June 2, 2023)
InnoCare Pharma (09969) announced that on July 15, 2026, it issued a total of 512,500 new RMB shares to 2 directors based on the attribution results of the third vesting period of the RMB stock incentive plan in 2023 (adopted on June 2, 2023). On July 15, 2026, based on the attribution results of the third vesting period of the RMB stock incentive plan in 2023, the company issued 125,000 new RMB shares to 1 senior management personnel (adopted on June 2, 2023). On July 15, 2026, based on the attribution results of the third vesting period of the RMB stock incentive plan in 2023, the company issued 1,004,000 new RMB shares to 88 incentive recipients (adopted on June 2, 2023). On July 15, 2026, based on the reserved attribution results of the second vesting period of the RMB stock incentive plan in 2023, the company issued 403,250 new RMB shares to 43 incentive recipients (adopted on June 2, 2023).